In in vitro fertilization (IVF) treatments, it is common to obtain more embryos than are transferred in a single cycle. These surplus embryos, usually of good quality, are vitrified for storage and potential future use. Managing these embryos presents important decisions for both patients and assisted reproduction clinics.
According to Spain’s Law 14/2006 on assisted human reproduction techniques, cryopreserved embryos can have the following outcomes:
Personal use: The embryos can be used by the couple or the woman for future pregnancy attempts, avoiding the need for new ovarian stimulation and follicular puncture.
Donation to other couples: Embryos can be voluntarily and altruistically donated to individuals who require assisted reproduction treatments.
Donation for research: Embryos may be provided for scientific research projects, provided that detailed information and specific consent from the parents are obtained.
Discontinuation of storage: The destruction of embryos is only possible when the woman no longer meets the necessary conditions for assisted reproduction techniques, a decision that must be determined by specialists independent of the clinic where the embryos are stored.
It is mandatory for couples or individuals to renew their consent regarding embryo storage every two years. However, in some cases, no response is received, leading to the situation of abandoned embryos. If, after two attempts at renewal, the clinic cannot contact the parents, the embryos are placed under the clinic’s jurisdiction and may be assigned to any of the legally established options while maintaining confidentiality and anonymity.
(*Source: Reproducción Asistida ORG)
The management of surplus embryos presents ethical and regulatory dilemmas. Decisions regarding their fate must be informed and consensual, considering legal, ethical, and personal factors. It is crucial for clinics to provide clear and detailed information to patients to facilitate responsible and well-informed decisions.
(*Source: SciELO)
Managing surplus embryos and their storage can be a challenge for assisted reproduction clinics. ReproCopilot offers innovative solutions through its specialized software “Cuida tu embrión”, designed to automate cryopreservation management, reducing administrative workload and ensuring regulatory compliance.
✅ Automated cryopreservation management: Ensures efficient handling of vitrified embryos, maintaining proper tracking and timely consent renewal.
✅ Reduced operational costs: Minimizes human intervention in administrative processes, optimizing clinic staff time.
✅ Enhanced traceability and security: Provides full control over the status and fate of each embryo, ensuring ethical and legal compliance.
Additionally, ReproCopilot offers a specialized infertility software that helps clinics improve treatment protocols and optimize patient care with an AI-based approach.
Technology and innovation in assisted reproduction are constantly evolving, and tools like those offered by ReproCopilot enable clinics to provide more efficient, personalized services aligned with industry best practices.
To learn more about Cuida tu embrión and ReproCopilot’s infertility software, visit our website: www.reprocopilot.ai
The management of surplus embryos in IVF treatments is a complex issue that requires informed and thoughtful decisions. The available options, regulated by law, aim to balance scientific advancements with ethical and personal considerations, ensuring a respectful and appropriate approach to cryopreserved embryo management.
With innovative solutions like ReproCopilot, assisted reproduction clinics can optimize embryo management and provide patients with higher-quality care and transparency.